Gerresheimer

Gerresheimer is a prominent global partner in the pharmaceutical and healthcare sectors, focusing on specialty glass and plastic products that enhance health and well-being. With approximately 10,000 employees, the company operates numerous manufacturing plants across Europe, North America, South America, and Asia, generating revenues around EUR 1.4 billion. Its diverse product portfolio includes pharmaceutical packaging, drug delivery devices, and solutions that facilitate the safe and effective administration of medicines, such as insulin pens, inhalers, refillable syringes, injection vials, ampoules, and various containers. Additionally, Gerresheimer produces packaging for the cosmetics industry and offers advanced technologies aimed at improving patient therapy outcomes. The majority of the company's revenue is derived from its operations in Europe, particularly Germany, where it maintains a strong market presence.

Bernd Metzner Ph.D

CFO and Member of the Management Board

3 past transactions

Adamant Health

Seed Round in 2022
Developer of motion and electromyography measurement and analysis devices designed to revolutionize the care of parkinson's disease. The company offers advanced-generation measurement and analysis tools available for clinical use based on combined electromyography and motion sensor data that analyze algorithms detecting parkinson's disease-specific symptoms from the data, using electromyography to measure the symptoms of the disease, enabling physicians to understand the patients and the condition both at home and in the hospital.

Sensile Medical

Acquisition in 2018
Sensile Medical AG specializes in the development of innovative medical devices for glucose monitoring and micro drug delivery systems. Founded in 2004 and based in Hägendorf, Switzerland, the company creates highly customizable, nanoliter-based devices that enhance patient care and improve quality of life. Sensile Medical's technology focuses on safe and cost-efficient liquid drug delivery solutions, offering both reusable and disposable devices to optimize therapy costs and minimize waste. The company has established strategic partnerships with organizations such as scPharmaceuticals LLC, Sanofi, and Verily, and is recognized for its advancements in on- and off-body drug delivery systems. In 2018, Sensile Medical became a subsidiary of Gerresheimer AG, further expanding its capabilities in the medical device sector.

Centor

Acquisition in 2015
Centor manufactures plastic vials and closures used by pharmacies to deliver exact dosages of medication to patients. Nemera designs, produces and sells a range of medical devices including inhalers, insulin pens and pumps.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.